Differential cognitive effects of carbamazepine and gabapentin

K. J. Meador, D. W. Loring, Patty G Ray, Anthony M Murro, D. W. King, M. E. Nichols, E. M. Deer, W. T. Goff

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

Purpose: The cognitive effects of the newer antiepileptic drugs (AEDs) compared with the older standard AEDs are uncertain. Methods: We directly compared the cognitive effects of carbamazepine (CBZ) and gabapentin (GBP) in 35 healthy subjects by using a double-blind, randomized crossover design with two 5-week treatment periods. During each treatment condition, subjects received either GBP, 2,400 mg/day, or CBZ (mean, 731 mg/day) adjusted to a dose to achieve midrange standard therapeutic blood levels (mean, 8.3 μg/ml). Subjects were tested at the end of each AED treatment period and in four drug-free conditions [two pretreatment baselines and two post-treatment washout periods (1 month after each AED)]. The neuropsychological test battery included 17 measures yielding 31 total variables. Results: Direct comparison of the two AEDs revealed significantly better performance on eight variables for GBP, but none for CBZ. Comparison of CBZ and GBP to the nondrug average revealed significant statistical differences for 15 (48%) of 31 the variables. Pairwise follow-up analyses of the 15 variables revealed significantly better performance for nondrug average on 13 variables compared with CBZ, and on four compared with GBP. GBP was better than nondrug average on one variable. Conclusions: Although both CBZ and GBP produced some effects, GBP produced significantly fewer untoward cognitive effects compared with CBZ at the dosages used in this study.

Original languageEnglish (US)
Pages (from-to)1279-1285
Number of pages7
JournalEpilepsia
Volume40
Issue number9
DOIs
StatePublished - Sep 13 1999

Fingerprint

Carbamazepine
Anticonvulsants
Therapeutics
gabapentin
Neuropsychological Tests
Cross-Over Studies
Healthy Volunteers
Pharmaceutical Preparations

Keywords

  • Carbamazepine
  • Cognition
  • EEG
  • Gabapentin
  • P3 potential

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Meador, K. J., Loring, D. W., Ray, P. G., Murro, A. M., King, D. W., Nichols, M. E., ... Goff, W. T. (1999). Differential cognitive effects of carbamazepine and gabapentin. Epilepsia, 40(9), 1279-1285. https://doi.org/10.1111/j.1528-1157.1999.tb00858.x

Differential cognitive effects of carbamazepine and gabapentin. / Meador, K. J.; Loring, D. W.; Ray, Patty G; Murro, Anthony M; King, D. W.; Nichols, M. E.; Deer, E. M.; Goff, W. T.

In: Epilepsia, Vol. 40, No. 9, 13.09.1999, p. 1279-1285.

Research output: Contribution to journalArticle

Meador, KJ, Loring, DW, Ray, PG, Murro, AM, King, DW, Nichols, ME, Deer, EM & Goff, WT 1999, 'Differential cognitive effects of carbamazepine and gabapentin', Epilepsia, vol. 40, no. 9, pp. 1279-1285. https://doi.org/10.1111/j.1528-1157.1999.tb00858.x
Meador KJ, Loring DW, Ray PG, Murro AM, King DW, Nichols ME et al. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia. 1999 Sep 13;40(9):1279-1285. https://doi.org/10.1111/j.1528-1157.1999.tb00858.x
Meador, K. J. ; Loring, D. W. ; Ray, Patty G ; Murro, Anthony M ; King, D. W. ; Nichols, M. E. ; Deer, E. M. ; Goff, W. T. / Differential cognitive effects of carbamazepine and gabapentin. In: Epilepsia. 1999 ; Vol. 40, No. 9. pp. 1279-1285.
@article{c00807a96cf747e68a4389f9e24810eb,
title = "Differential cognitive effects of carbamazepine and gabapentin",
abstract = "Purpose: The cognitive effects of the newer antiepileptic drugs (AEDs) compared with the older standard AEDs are uncertain. Methods: We directly compared the cognitive effects of carbamazepine (CBZ) and gabapentin (GBP) in 35 healthy subjects by using a double-blind, randomized crossover design with two 5-week treatment periods. During each treatment condition, subjects received either GBP, 2,400 mg/day, or CBZ (mean, 731 mg/day) adjusted to a dose to achieve midrange standard therapeutic blood levels (mean, 8.3 μg/ml). Subjects were tested at the end of each AED treatment period and in four drug-free conditions [two pretreatment baselines and two post-treatment washout periods (1 month after each AED)]. The neuropsychological test battery included 17 measures yielding 31 total variables. Results: Direct comparison of the two AEDs revealed significantly better performance on eight variables for GBP, but none for CBZ. Comparison of CBZ and GBP to the nondrug average revealed significant statistical differences for 15 (48{\%}) of 31 the variables. Pairwise follow-up analyses of the 15 variables revealed significantly better performance for nondrug average on 13 variables compared with CBZ, and on four compared with GBP. GBP was better than nondrug average on one variable. Conclusions: Although both CBZ and GBP produced some effects, GBP produced significantly fewer untoward cognitive effects compared with CBZ at the dosages used in this study.",
keywords = "Carbamazepine, Cognition, EEG, Gabapentin, P3 potential",
author = "Meador, {K. J.} and Loring, {D. W.} and Ray, {Patty G} and Murro, {Anthony M} and King, {D. W.} and Nichols, {M. E.} and Deer, {E. M.} and Goff, {W. T.}",
year = "1999",
month = "9",
day = "13",
doi = "10.1111/j.1528-1157.1999.tb00858.x",
language = "English (US)",
volume = "40",
pages = "1279--1285",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Differential cognitive effects of carbamazepine and gabapentin

AU - Meador, K. J.

AU - Loring, D. W.

AU - Ray, Patty G

AU - Murro, Anthony M

AU - King, D. W.

AU - Nichols, M. E.

AU - Deer, E. M.

AU - Goff, W. T.

PY - 1999/9/13

Y1 - 1999/9/13

N2 - Purpose: The cognitive effects of the newer antiepileptic drugs (AEDs) compared with the older standard AEDs are uncertain. Methods: We directly compared the cognitive effects of carbamazepine (CBZ) and gabapentin (GBP) in 35 healthy subjects by using a double-blind, randomized crossover design with two 5-week treatment periods. During each treatment condition, subjects received either GBP, 2,400 mg/day, or CBZ (mean, 731 mg/day) adjusted to a dose to achieve midrange standard therapeutic blood levels (mean, 8.3 μg/ml). Subjects were tested at the end of each AED treatment period and in four drug-free conditions [two pretreatment baselines and two post-treatment washout periods (1 month after each AED)]. The neuropsychological test battery included 17 measures yielding 31 total variables. Results: Direct comparison of the two AEDs revealed significantly better performance on eight variables for GBP, but none for CBZ. Comparison of CBZ and GBP to the nondrug average revealed significant statistical differences for 15 (48%) of 31 the variables. Pairwise follow-up analyses of the 15 variables revealed significantly better performance for nondrug average on 13 variables compared with CBZ, and on four compared with GBP. GBP was better than nondrug average on one variable. Conclusions: Although both CBZ and GBP produced some effects, GBP produced significantly fewer untoward cognitive effects compared with CBZ at the dosages used in this study.

AB - Purpose: The cognitive effects of the newer antiepileptic drugs (AEDs) compared with the older standard AEDs are uncertain. Methods: We directly compared the cognitive effects of carbamazepine (CBZ) and gabapentin (GBP) in 35 healthy subjects by using a double-blind, randomized crossover design with two 5-week treatment periods. During each treatment condition, subjects received either GBP, 2,400 mg/day, or CBZ (mean, 731 mg/day) adjusted to a dose to achieve midrange standard therapeutic blood levels (mean, 8.3 μg/ml). Subjects were tested at the end of each AED treatment period and in four drug-free conditions [two pretreatment baselines and two post-treatment washout periods (1 month after each AED)]. The neuropsychological test battery included 17 measures yielding 31 total variables. Results: Direct comparison of the two AEDs revealed significantly better performance on eight variables for GBP, but none for CBZ. Comparison of CBZ and GBP to the nondrug average revealed significant statistical differences for 15 (48%) of 31 the variables. Pairwise follow-up analyses of the 15 variables revealed significantly better performance for nondrug average on 13 variables compared with CBZ, and on four compared with GBP. GBP was better than nondrug average on one variable. Conclusions: Although both CBZ and GBP produced some effects, GBP produced significantly fewer untoward cognitive effects compared with CBZ at the dosages used in this study.

KW - Carbamazepine

KW - Cognition

KW - EEG

KW - Gabapentin

KW - P3 potential

UR - http://www.scopus.com/inward/record.url?scp=0032872770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032872770&partnerID=8YFLogxK

U2 - 10.1111/j.1528-1157.1999.tb00858.x

DO - 10.1111/j.1528-1157.1999.tb00858.x

M3 - Article

C2 - 10487192

AN - SCOPUS:0032872770

VL - 40

SP - 1279

EP - 1285

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 9

ER -